- About
- Advertise / Support
- Contact
- CancerNetwork.com
- TargetedOnc.com
- OncLive.com
- OncNursingNews.com
- Terms & Conditions
- Privacy
- Do Not Sell My Information
© 2024 MJH Life Sciences™ and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
What Patients With Blood Cancers Need to Know About COVID-19, Booster Shots and More
Jamie Cesanek, Assistant Web Editor for CURE®, joined the team in March 2021. She graduated from Indiana University Bloomington, where she studied journalism and minored in sociology and French. In her free time, she enjoys hiking, running, or enjoying time with friends and family. Email her at jcesanek@curetoday.com.
An expert from the Leukemia & Lymphoma Society breaks down the effectiveness of the COVID-19 vaccine in patients with blood cancers on this episode of the “Cancer Horizons” podcast.
With recent research demonstrating that antibodies were not detected in some patients with B-cell blood cancers after receiving two doses of the COVID-19 vaccine, many people have questions. Will a third dose help these patients? Should they bother with the vaccine? How do their current cancer treatments impact the vaccine’s effectiveness?
Dr. Larry Saltzman, the executive research director at the Leukemia & Lymphoma Society, answered these questions and more in this episode of the “Cancer Horizons” podcast.
“So there's two swings of the pendulum, those who will respond in a global, very good way – not to worry, essentially, and those (who) will not respond due to the treatments that they're on,” Saltzman said.
For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Related Content:
